Across TCGA pan-cancer cohorts, S100A15A RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of S100A15A’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where S100A15A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types S100A15A is over-expressed in tumor.

LUSC and BRCA are the cancer types where S100A15A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in S100A15A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.886	<.001	5	view →
BRCA	Female	II,III,IV	+0.121	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: S100A15A RNA expression & survival · all S100A15A data types